Stockscreener 앱 받기
1.2668
6.45%
0.0768
전일 마감가:
$1.19
열려 있는:
$1.2
하루 거래량:
94,534
Relative Volume:
0.04
시가총액:
$4.81M
수익:
$2.45M
순이익/손실:
$-5.47M
주가수익비율:
-0.0214
EPS:
-59.1634
순현금흐름:
$-6.05M
1주 성능:
-23.22%
1개월 성능:
-34.02%
6개월 성능:
-97.78%
1년 성능:
-99.10%
1일 변동 폭
$1.19
$1.2804
1주일 범위
$1.16
$1.67
52주 변동 폭
$1.16
$165.96
Pmgc Holdings Inc Stock (ELAB) Company Profile
명칭
Pmgc Holdings Inc
전화
18667944940
주소
120 NEWPORT CENTER DRIVE, NEWPORT BEACH
ELAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAB
Pmgc Holdings Inc
|
1.2668 | 4.81M | 2.45M | -5.47M | -6.05M | -59.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.93 | 121.85B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.99 | 76.83B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
619.74 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.49 | 30.69B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
269.89 | 29.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Pmgc Holdings Inc 주식(ELAB)의 최신 뉴스
PMGC Holdings Inc. Announces Annual Sponsorship of TCA Venture Group's Orange County Network for 2025 - Nasdaq
PMGC Holdings Inc. Expands Investment & M&A Efforts, - GlobeNewswire
PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group - StockTitan
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced ... - The Bakersfield Californian
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market - GlobeNewswire
Is PMGC Holdings' Debt-Free Status Enough to Counter Its 335K Short Interest? - StockTitan
Elevai Labs stock hits 52-week low at $1.58 amid steep decline - Investing.com Canada
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings - GlobeNewswire
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with G - The Manila Times
Revolutionary Obesity Drug EL-22 Advances: Could Solve GLP-1's Biggest Problem - StockTitan
What Did We Find About Insider Trading At PMGC Holdings Inc (NASDAQ: ELAB)? - Stocks Register
Elevai Labs Inc. announced that it expects to receive $1 million in funding -July 30, 2024 - Marketscreener.com
ELABPMGC Holdings Latest Stock News & Market Updates - StockTitan
Elevai Labs stock plunges to 52-week low of $1.61 amid steep decline - Investing.com Australia
Elevai Labs stock plunges to 52-week low of $1.61 amid steep decline By Investing.com - Investing.com South Africa
PMGC Holdings (NASDAQ:ELAB) Stock Quotes, Forecast and News Summary - Benzinga
The -96.65% Simple Moving Average of PMGC Holdings Inc’s (ELAB) Stock in the Past 200 Days - The News Heater
ELAB’s 2023 Market Dance: Down -19.21% – Time to Invest? - The InvestChronicle
Northstrive Biosciences, Inc., a Subsidiary of PMGC - GlobeNewswire
Evaluating ELAB’s financial ratios for a profitable investment - US Post News
Northstrive Biosciences, Subsidiary of PMGC Holdings, Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1 - Marketscreener.com
Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1 - The Manila Times
Obesity Drug Breakthrough: Dual-Action Treatment Could Revolutionize Weight Loss While Protecting Muscle Mass - StockTitan
PMGC Stock Surges On Invitation To Present ‘Probiotic’ For Preventing Muscle Loss: Retail Chatter Spikes - MSN
PMGC Holdings announces equity sale through warrant inducement - MSN
PMGC Holdings Inc. Initiates Strategic Investments in Fire Prevention Technology and U.S. Uranium Energy Market - Nasdaq
PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., - GlobeNewswire
Uranium & Fire Tech: PMGC's Bold Move Targets Two Red-Hot Growth Sectors - StockTitan
PMGC Capital Builds Portfolio with Acquisition Of US Focused Uranium Energy & Fire Prevention Tech Co's - TradingView
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Signs Agreement For Preclinical Mouse Study of EL-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 - GlobeNewswire
Revolutionary Weight Loss Breakthrough: This Biotech's Solution Could Fix GLP-1's Biggest Problem - StockTitan
Elevai Labs Inc. Enters Into Warrant Inducement Agreement - Defense World
PMGC Holdings meets Nasdaq compliance; subsidiaries rebrand - MSN
PMGC Holdings announces equity sale through warrant inducement By Investing.com - Investing.com Canada
Univest Securities, LLC Announces Closing of $1.92 Million - GlobeNewswire
Univest Securities, LLC Announces Closing of $1.92 Million Warrant Inducement for its Client PMGC Holdings - EIN News
Elevai Labs stock hits 52-week low at $1.74 amid steep annual decline - MSN
3 Penny Stocks to Watch Now, 1/28/25 - TipRanks
PMGC Holdings strikes deal to exercise warrants, raise $1.9 million By Investing.com - Investing.com Nigeria
Elevai Labs stock hits 52-week low at $1.74 amid steep annual decline By Investing.com - Investing.com South Africa
Carmell Closes Purchase of Elevai Skincare - Orange County Business Journal
Dow Edges Higher; AT&T Posts Upbeat Earnings - Benzinga
Stock market today: Allakos dropped by 76.37% whereas Onconetix jumped by 77.10% in early trading - Business Upturn
PMGC Holdings strikes deal to exercise warrants, raise $1.9 million - Investing.com
Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December - Benzinga
PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors - GlobeNewswire
PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors - GlobeNewswire Inc.
Pmgc Holdings Inc (ELAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.83%
0.59%
자본화:
|
볼륨(24시간):